The Nigeria Centre for Disease Control (NCDC) reported 1,138 new infections of COVID-19 Wednesday.
In a Twitter update via its verified handle, the government agency said there are now 134,690 confirmed cases of the disease caused by the novel coronavirus in Nigeria.
A total of 108,657 people it stated, have so far been discharged from hospital, while the number of deaths so far is 1,618.
As of Wednesday, more than 104.2 million cases of COVID-19 had been reported worldwide, with more than 57.7 million of those listed as recovered or resolved, according to a tracking tool maintained by Johns Hopkins University. The global death toll stood at more than 2.2 million.
Meanwhile, according to the CBC, a United Nations-backed programme to deploy COVID-19 vaccines to the neediest people worldwide has announced plans for an initial distribution of more than 100 million doses by the end of the first quarter.
The COVAX Facility says it aims for nearly 200 million doses by the end of June. Most of the vaccines in the first phase will be from AstraZeneca and the Serum Institute of India.
Another 1.2 million doses of a vaccine from Pfizer are expected to be shared by 18 countries in the first quarter.
That is even as the new Oxford vaccine is said to be ready by the autumn to tackle mutations.
A BBC report said Prof Andy Pollard, from Oxford University, said tweaking a vaccine was a relatively quick process and would only need small trials before roll-out.
It has emerged that patients ‘can catch two strains of COVID-19 at same time’ as cases emerge in Brazil.
Metro, citing a study, reports that two patients in Brazil tested positive for more than one strain of COVID-19 at the same time. Scientists from Feevale University swabbed 92 people with coronavirus in Rio Grande do Sul, southern Brazil. The patients were aged 14 to 80 years old, while 50% were men and 50% were women. Two people in the study were found to have been infected with two different strains of the virus in November 2020, according to local media. However, the combination of the two strains did not appear to worsen the disease and the patients suffered a mild to moderate illness. They have since recovered. The study,